To compare the impact of the modulation of SMAD2 or SMAD3 expression on the invasive properties of cancer cells, we used HT-1080 and MDA-MB-231 cells overexpressing shRNA directed against SMAD2 or SMAD3. The gene discussed is SMAD2; the disease is cancer.